Xi‐Ding Yang

788 total citations
18 papers, 588 citations indexed

About

Xi‐Ding Yang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xi‐Ding Yang has authored 18 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xi‐Ding Yang's work include Ferroptosis and cancer prognosis (2 papers), Chronic Kidney Disease and Diabetes (2 papers) and Natural product bioactivities and synthesis (2 papers). Xi‐Ding Yang is often cited by papers focused on Ferroptosis and cancer prognosis (2 papers), Chronic Kidney Disease and Diabetes (2 papers) and Natural product bioactivities and synthesis (2 papers). Xi‐Ding Yang collaborates with scholars based in China. Xi‐Ding Yang's co-authors include Yong‐Yu Yang, Dongsheng Ouyang, Guoping Yang, Daxiong Xiang, Rongrong Deng, Pingfei Fang, Chang‐Ping Hu, Yingjun Zhou, Bing Xu and Guangyao Zeng and has published in prestigious journals such as Medicine, Diabetes Obesity and Metabolism and Frontiers in Endocrinology.

In The Last Decade

Xi‐Ding Yang

17 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi‐Ding Yang China 11 360 128 88 71 67 18 588
Yong‐Yu Yang China 15 456 1.3× 155 1.2× 108 1.2× 80 1.1× 75 1.1× 31 817
Yong Su China 15 365 1.0× 102 0.8× 68 0.8× 59 0.8× 40 0.6× 36 665
Lingpeng Xie China 19 337 0.9× 108 0.8× 92 1.0× 51 0.7× 95 1.4× 27 744
Zhishen Xie China 17 439 1.2× 98 0.8× 122 1.4× 97 1.4× 134 2.0× 54 850
Deepshikha Pande Katare India 12 244 0.7× 70 0.5× 83 0.9× 148 2.1× 54 0.8× 51 704
Liuyi Dong China 16 306 0.8× 62 0.5× 98 1.1× 52 0.7× 39 0.6× 26 692
Ke Tian China 10 257 0.7× 98 0.8× 59 0.7× 43 0.6× 44 0.7× 23 635
Shangfu Xu China 18 350 1.0× 192 1.5× 55 0.6× 51 0.7× 84 1.3× 41 764
Xianyong Bai China 13 290 0.8× 116 0.9× 72 0.8× 31 0.4× 29 0.4× 20 641
Pengji Yi China 13 300 0.8× 89 0.7× 66 0.8× 112 1.6× 28 0.4× 15 542

Countries citing papers authored by Xi‐Ding Yang

Since Specialization
Citations

This map shows the geographic impact of Xi‐Ding Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi‐Ding Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi‐Ding Yang more than expected).

Fields of papers citing papers by Xi‐Ding Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi‐Ding Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi‐Ding Yang. The network helps show where Xi‐Ding Yang may publish in the future.

Co-authorship network of co-authors of Xi‐Ding Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xi‐Ding Yang. A scholar is included among the top collaborators of Xi‐Ding Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi‐Ding Yang. Xi‐Ding Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yang, Xi‐Ding. (2024). Clinical Pharmacokinetics of Semaglutide: A Systematic Review. Drug Design Development and Therapy. Volume 18. 2555–2570. 25 indexed citations
2.
Yang, Xi‐Ding, Lingfeng Yang, Jingjing Li, et al.. (2024). Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis. European Journal of Clinical Pharmacology. 80(8). 1181–1187. 3 indexed citations
3.
Yang, Xi‐Ding, Rongrong Deng, & Daxiong Xiang. (2024). Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway. Drug Design Development and Therapy. Volume 18. 1499–1514. 10 indexed citations
4.
5.
Yang, Xi‐Ding, Ronghua Zhu, Jing Zhang, et al.. (2023). First-in-human phase I studies of YJ001 spray applied to local skin in healthy subjects and patients with diabetic neuropathic pain. Expert Opinion on Investigational Drugs. 32(6). 553–562. 3 indexed citations
6.
Yang, Xi‐Ding, Xiaojun Chen, Jinɡjinɡ Li, et al.. (2023). Pharmacokinetics and bioequivalence of two metoprolol succinate extended release tablets in healthy Chinese subjects under fasting and fed conditions. International Journal of Clinical Pharmacology and Therapeutics. 62(2). 101–108. 2 indexed citations
7.
Yang, Xi‐Ding, et al.. (2022). Potential lipolytic regulators derived from natural products as effective approaches to treat obesity. Frontiers in Endocrinology. 13. 1000739–1000739. 19 indexed citations
8.
Yang, Xi‐Ding & Yong‐Yu Yang. (2022). Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications. Frontiers in Endocrinology. 13. 853822–853822. 84 indexed citations
9.
Yang, Yong‐Yu, et al.. (2021). Piperazine ferulate attenuates high glucose‑induced mesangial cell injury via the regulation of p66Shc. Molecular Medicine Reports. 23(5). 12 indexed citations
10.
Yang, Yong‐Yu, et al.. (2021). Piperazine ferulate prevents high‑glucose‑induced filtration barrier injury of glomerular endothelial cells. Experimental and Therapeutic Medicine. 22(4). 1175–1175. 45 indexed citations
11.
Yang, Xi‐Ding, Lingfeng Yang, Jingjing Li, et al.. (2021). Evaluation of bioequivalence between generic and brand-name clozapine in Chinese schizophrenic patients: A randomized, two-period, crossover study. International Journal of Clinical Pharmacology and Therapeutics. 59(8). 578–584. 3 indexed citations
12.
Yang, Xi‐Ding, Zhuo Chen, Ling Ye, Jing Chen, & Yong‐Yu Yang. (2021). Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1/NF-κB p65 pathway. Pharmaceutical Biology. 59(1). 920–930. 26 indexed citations
13.
Yang, Xi‐Ding, Pingfei Fang, Daxiong Xiang, & Yong‐Yu Yang. (2019). Topical treatments for diabetic neuropathic pain (Review). Experimental and Therapeutic Medicine. 17(3). 1963–1976. 37 indexed citations
14.
Hou, Zhenyan, Miao Yan, Hualin Cai, et al.. (2018). Simple and rapid UPLC-MS/MS method for quantification of entecavir in human plasma: Application to a bioequivalence study. International Journal of Clinical Pharmacology and Therapeutics. 56(4). 197–204. 2 indexed citations
15.
Yang, Xi‐Ding, Daxiong Xiang, & Yong‐Yu Yang. (2016). Role of E3 ubiquitin ligases in insulin resistance. Diabetes Obesity and Metabolism. 18(8). 747–754. 28 indexed citations
16.
Pei, Qi, Jinfu Peng, Hongyi Tan, et al.. (2014). Cytochrome P450 2D6*10 genotype affects the pharmacokinetics of dimemorfan in healthy Chinese subjects. European Journal of Drug Metabolism and Pharmacokinetics. 40(4). 427–433. 3 indexed citations
17.
Yang, Xi‐Ding, Yong‐Yu Yang, Dongsheng Ouyang, & Guoping Yang. (2014). A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia. 100. 208–220. 218 indexed citations
18.
Yang, Yong‐Yu, Xi‐Ding Yang, Bing Xu, et al.. (2014). Chemical constituents of Morus alba L. and their inhibitory effect on 3T3-L1 preadipocyte proliferation and differentiation. Fitoterapia. 98. 222–227. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yong‐Yu Yang Breakdown of academic impact, for papers by Yong Su Breakdown of academic impact, for papers by Lingpeng Xie Breakdown of academic impact, for papers by Zhishen Xie Breakdown of academic impact, for papers by Deepshikha Pande Katare Breakdown of academic impact, for papers by Liuyi Dong Breakdown of academic impact, for papers by Ke Tian Breakdown of academic impact, for papers by Shangfu Xu Breakdown of academic impact, for papers by Xianyong Bai Breakdown of academic impact, for papers by Pengji Yi
Rankless by CCL
2026